Assess whether to report a refusal for shy bladder (421782)

SITUATION After a collector who skipped the bluing agent, prescription that could explain an opioid positive is what oral-fluid implementation lead can touch in a federal contractor under an HHS-mandatory program. Forensic Drug Testing will live with Accept the result versus Reject on custody on this Program Design and Audit file.

DECISION Oral-fluid implementation lead in a federal contractor under an HHS-mandatory program must choose Accept the result / Reject on custody / Recollect / Hold using prescription that could explain an opioid positive after a collector who skipped the bluing agent.

HYPOTHESES TO TEST 1. Prescription that could explain an opioid positive reads as Accept the result once a collector who skipped the bluing agent is lined up to the same Forensic Drug Testing population. 2. Prescription that could explain an opioid positive is closer to Reject on custody after a collector who skipped the bluing agent; Accept the result would over-claim this Program Design and Audit extract. 3. Recollect is still live in prescription that could explain an opioid positive for oral-fluid implementation lead in a federal contractor under an HHS-mandatory program. 4. Prescription that could explain an opioid positive is missing the fact oral-fluid implementation lead needs after a collector who skipped the bluing agent; stop this Forensic Drug Testing close.

ANALYSIS REQUIRED 1. Check MRO notes and cutoffs against the protocol a federal contractor under an HHS-mandatory program claims to run. 2. Walk chain of custody, collection site, and validity flags in prescription that could explain an opioid positive after a collector who skipped the bluing agent. 3. Name the step oral-fluid implementation lead cannot reconstruct from prescription that could explain an opioid positive. 4. For this Forensic Drug Testing Program Design and Audit file, read prescription that could explain an opioid positive against a collector who skipped the bluing agent and write the one fact that would move to report a refusal for oral-fluid implementation lead.

RECOMMENDATION Choose Accept the result / Reject on custody / Recollect / Hold on this Forensic Drug Testing / Program Design and Audit packet (prescription that could explain an opioid positive after a collector who skipped the bluing agent). If prescription that could explain an opioid positive cannot force a Forensic Drug Testing label under Program Design and Audit, stop. If prescription that could explain an opioid positive after a collector who skipped the bluing agent cannot support Accept the result versus Reject on custody on this Forensic Drug Testing Program Design and Audit close, oral-fluid implementation lead must do not accept, reject, or recollect beyond what custody and validity support.